These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 31343277)
1. The efficacy and potential mechanism of cnidium lactone to inhibit osteoclast differentiation. Liang JY; Wu WL; Chen YX; Liu H Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3087-3093. PubMed ID: 31343277 [TBL] [Abstract][Full Text] [Related]
2. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling. Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799 [TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells. Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020 [TBL] [Abstract][Full Text] [Related]
4. Dehydrocostus lactone inhibits NFATc1 via regulation of IKK, JNK, and Nrf2, thereby attenuating osteoclastogenesis. Lee HI; Lee GR; Lee J; Kim N; Kwon M; Kim HJ; Kim NY; Park JH; Jeong W BMB Rep; 2020 Apr; 53(4):218-222. PubMed ID: 31964469 [TBL] [Abstract][Full Text] [Related]
5. Idelalisib inhibits osteoclast differentiation and pre-osteoclast migration by blocking the PI3Kδ-Akt-c-Fos/NFATc1 signaling cascade. Yeon JT; Kim KJ; Son YJ; Park SJ; Kim SH Arch Pharm Res; 2019 Aug; 42(8):712-721. PubMed ID: 31161369 [TBL] [Abstract][Full Text] [Related]
6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [TBL] [Abstract][Full Text] [Related]
7. Bergapten suppresses RANKL-induced osteoclastogenesis and ovariectomy-induced osteoporosis via suppression of NF-κB and JNK signaling pathways. Chen G; Xu Q; Dai M; Liu X Biochem Biophys Res Commun; 2019 Feb; 509(2):329-334. PubMed ID: 30579598 [TBL] [Abstract][Full Text] [Related]
8. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways. Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053 [TBL] [Abstract][Full Text] [Related]
9. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Huang H; Chang EJ; Ryu J; Lee ZH; Lee Y; Kim HH Biochem Biophys Res Commun; 2006 Dec; 351(1):99-105. PubMed ID: 17052691 [TBL] [Abstract][Full Text] [Related]
10. The Effects of Aronia melanocarpa 'Viking' Extracts in Attenuating RANKL-Induced Osteoclastic Differentiation by Inhibiting ROS Generation and c-FOS/NFATc1 Signaling. Ghosh M; Kim IS; Lee YM; Hong SM; Lee TH; Lim JH; Debnath T; Lim BO Molecules; 2018 Mar; 23(3):. PubMed ID: 29518052 [TBL] [Abstract][Full Text] [Related]
11. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo. Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094 [TBL] [Abstract][Full Text] [Related]
12. Diarylheptanoid from Curcuma comosa Roxb. suppresses RANKL-induced osteoclast differentiation by decreasing NFATc1 and c-Fos expression via MAPK pathway. Chawalitpong S; Sornkaew N; Suksamrarn A; Palaga T Eur J Pharmacol; 2016 Oct; 788():351-359. PubMed ID: 27523282 [TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731 [TBL] [Abstract][Full Text] [Related]
14. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1. Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419 [TBL] [Abstract][Full Text] [Related]
15. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts. Kim MH; Ryu SY; Choi JS; Min YK; Kim SH J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230 [TBL] [Abstract][Full Text] [Related]
16. Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility. Jin SH; Kim H; Gu DR; Park KH; Lee YR; Choi Y; Lee SH BMB Rep; 2018 Jul; 51(7):356-361. PubMed ID: 29921413 [TBL] [Abstract][Full Text] [Related]
17. Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat. Lee KY; Kim JH; Kim EY; Yeom M; Jung HS; Sohn Y BMC Complement Altern Med; 2019 Aug; 19(1):207. PubMed ID: 31399090 [TBL] [Abstract][Full Text] [Related]
18. Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo. Tran PT; Dang NH; Kim O; Van Cuong P; Dat NT; Hwangbo C; Van Minh C; Lee JH Phytomedicine; 2019 Jun; 59():152908. PubMed ID: 30981187 [TBL] [Abstract][Full Text] [Related]
19. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT. Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828 [TBL] [Abstract][Full Text] [Related]
20. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. Kim JY; Kim JY; Kim JJ; Oh J; Kim YC; Lee MS Biol Pharm Bull; 2014; 37(2):255-61. PubMed ID: 24492722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]